nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit
|
Bostner, Josefine |
|
2012 |
137 |
2 |
p. 397-406 |
artikel |
2 |
Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer
|
Hayashi, Naoki |
|
2012 |
137 |
2 |
p. 523-531 |
artikel |
3 |
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
|
Eggemann, Holm |
|
2012 |
137 |
2 |
p. 465-470 |
artikel |
4 |
Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage
|
Conroy, Susan K. |
|
2012 |
137 |
2 |
p. 493-502 |
artikel |
5 |
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
|
Ma, Cynthia X. |
|
2012 |
137 |
2 |
p. 483-492 |
artikel |
6 |
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
|
Cristofanilli, Massimo |
|
2012 |
137 |
2 |
p. 471-482 |
artikel |
7 |
Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk
|
Wang, Hong |
|
2012 |
137 |
2 |
p. 511-522 |
artikel |
8 |
Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis
|
Pabalan, Noel |
|
2012 |
137 |
2 |
p. 553-558 |
artikel |
9 |
Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case–control study
|
Bilinski, K. |
|
2012 |
137 |
2 |
p. 599-607 |
artikel |
10 |
Comments on the use of a single or multiple probe-set approach for microarray-based analyses of routine molecular markers in breast cancer
|
Coradini, Danila |
|
2012 |
137 |
2 |
p. 647-651 |
artikel |
11 |
Differential expression of immune-related markers in breast cancer by molecular phenotypes
|
Choi, Junjeong |
|
2012 |
137 |
2 |
p. 417-429 |
artikel |
12 |
Effect of HER2 status on distant recurrence in early stage breast cancer
|
Hess, Kenneth R. |
|
2012 |
137 |
2 |
p. 449-455 |
artikel |
13 |
Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer
|
Dean-Colomb, Windy |
|
2012 |
137 |
2 |
p. 631-636 |
artikel |
14 |
Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features
|
Jambal, Purevsuren |
|
2012 |
137 |
2 |
p. 431-448 |
artikel |
15 |
Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population
|
Jara, Lilian |
|
2012 |
137 |
2 |
p. 559-569 |
artikel |
16 |
Impact of breast cancer on anti-mullerian hormone levels in young women
|
Su, H. I. |
|
2012 |
137 |
2 |
p. 571-577 |
artikel |
17 |
Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis
|
Antoni, Sebastien |
|
2012 |
137 |
2 |
p. 337-347 |
artikel |
18 |
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion
|
Bockhorn, Jessica |
|
2012 |
137 |
2 |
p. 373-382 |
artikel |
19 |
Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program
|
Cunningham, Joan E. |
|
2012 |
137 |
2 |
p. 589-598 |
artikel |
20 |
Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations
|
Prokofyeva, Darya |
|
2012 |
137 |
2 |
p. 533-539 |
artikel |
21 |
One-day core needle biopsy in a breast clinic: 4 years experience
|
Bulte, Joris P. |
|
2012 |
137 |
2 |
p. 609-616 |
artikel |
22 |
Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior
|
Forsythe, Laura P. |
|
2012 |
137 |
2 |
p. 617-630 |
artikel |
23 |
Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen
|
Yardley, Denise A. |
|
2012 |
137 |
2 |
p. 457-464 |
artikel |
24 |
Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes
|
Hanker, Lars C. |
|
2012 |
137 |
2 |
p. 407-416 |
artikel |
25 |
PTP1B expression is an independent positive prognostic factor in human breast cancer
|
Soysal, S. |
|
2012 |
137 |
2 |
p. 637-644 |
artikel |
26 |
Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age
|
Li, Christopher I. |
|
2012 |
137 |
2 |
p. 579-587 |
artikel |
27 |
Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism
|
Allensworth, Jennifer L. |
|
2012 |
137 |
2 |
p. 359-371 |
artikel |
28 |
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
|
Wallwiener, Markus |
|
2012 |
137 |
2 |
p. 503-510 |
artikel |
29 |
Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry
|
Zhang, Fang Fang |
|
2012 |
137 |
2 |
p. 541-551 |
artikel |
30 |
Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype
|
Brown, Kevin D. |
|
2012 |
137 |
2 |
p. 329-336 |
artikel |
31 |
Trastuzumab administration during pregnancy: a systematic review and meta-analysis
|
Zagouri, Flora |
|
2012 |
137 |
2 |
p. 349-357 |
artikel |
32 |
Unincluded subjects need to be included for concerning the real association between TNFa−308 G/A polymorphism and cancer susceptibility
|
Zhang, Guoqiang |
|
2012 |
137 |
2 |
p. 645-646 |
artikel |
33 |
Vimentin DNA methylation predicts survival in breast cancer
|
Ulirsch, Jacob |
|
2012 |
137 |
2 |
p. 383-396 |
artikel |